Fluoxetine for Visual Recovery After Ischemic Stroke "FLUORESCE"


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine whether fluoxetine, a selective serotonin reuptake inhibitor commonly used for depression, enhances visual recovery after an acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2017.

1 May 2016 1 Apr 2016 1 Jun 2020 1 Jun 2020 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment